To understand the possible molecular mechanisms underlying the inhibition of melanoma cell growth induced by metformin and binimetinib, the activity of genes encoding key proteins involved in the regulation of the cell cycle (CCND1 and CDKN1B) and apoptosis (BAX and BCL-2) was evaluated. This evidence concerns the gene BCL2 and melanoma.